02 November 2023
02 November 2023
The Clinical Trials Arena team also review assets in oncology, cardiovascular disorders and genito-urinary system indications.
Curavit will incorporate HEOR services into trials to elucidate the real-world financial impact of a new product.
The Sylvee device can diagnose chronic obstructive pulmonary disease with 90% accuracy.
CervoMed plans to read out data from the ongoing Phase IIb trial with neflamapimod by the end of 2024, which will inform the next development steps.
Jonathan Milner suspended his vote against campaign today in the wake of "extensive feedback" from Abcam shareholders.
Keytruda showed a statistically significant and clinically meaningful improvement in OS against placebo.
Zerlasiran offered a decline of up to 99% in lipoprotein(a) levels in atherosclerotic cardiovascular disease patients.
The nationally famous children’s hospital has partnered with ViroCell Biologics to produce the viral vectors necessary for certain cell and gene therapies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
